These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19799492)

  • 1. Plasmodium vivax DBP binding to Aotus nancymaae erythrocytes is Duffy antigen dependent.
    McHenry AM; Barnwell JW; Adams JH
    J Parasitol; 2010 Feb; 96(1):225-7. PubMed ID: 19799492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein.
    Grimberg BT; Udomsangpetch R; Xainli J; McHenry A; Panichakul T; Sattabongkot J; Cui L; Bockarie M; Chitnis C; Adams J; Zimmerman PA; King CL
    PLoS Med; 2007 Dec; 4(12):e337. PubMed ID: 18092885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine specificity of Plasmodium vivax Duffy binding protein binding engagement of the Duffy antigen on human erythrocytes.
    Siddiqui AA; Xainli J; Schloegel J; Carias L; Ntumngia F; Shoham M; Casey JL; Foley M; Adams JH; King CL
    Infect Immun; 2012 Aug; 80(8):2920-8. PubMed ID: 22615246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptome profiling of
    Gunalan K; Sá JM; Moraes Barros RR; Anzick SL; Caleon RL; Mershon JP; Kanakabandi K; Paneru M; Virtaneva K; Martens C; Barnwell JW; Ribeiro JM; Miller LH
    Proc Natl Acad Sci U S A; 2019 Apr; 116(14):7053-7061. PubMed ID: 30872477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting a Reticulocyte Binding Protein and Duffy Binding Protein to Inhibit Reticulocyte Invasion by Plasmodium vivax.
    Gupta S; Singh S; Popovici J; Roesch C; Shakri AR; Guillotte-Blisnick M; Huon C; Menard D; Chitnis CE
    Sci Rep; 2018 Jul; 8(1):10511. PubMed ID: 30002416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the Plasmodium vivax Duffy-binding protein.
    Chitnis CE; Sharma A
    Trends Parasitol; 2008 Jan; 24(1):29-34. PubMed ID: 18023618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of single versus mixed allele vaccines of Plasmodium vivax Duffy binding protein region II.
    Ntumngia FB; Schloegel J; McHenry AM; Barnes SJ; George MT; Kennedy S; Adams JH
    Vaccine; 2013 Sep; 31(40):4382-8. PubMed ID: 23916294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of a Plasmodium vivax erythrocyte binding protein by flow cytometry.
    Tran TM; Moreno A; Yazdani SS; Chitnis CE; Barnwell JW; Galinski MR
    Cytometry A; 2005; 63(1):59-66. PubMed ID: 15584018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Erythrocyte Binding Protein of Plasmodium vivax Suggests an Alternate Invasion Pathway into Duffy-Positive Reticulocytes.
    Ntumngia FB; Thomson-Luque R; Torres Lde M; Gunalan K; Carvalho LH; Adams JH
    mBio; 2016 Aug; 7(4):. PubMed ID: 27555313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody.
    Rawlinson TA; Barber NM; Mohring F; Cho JS; Kosaisavee V; Gérard SF; Alanine DGW; Labbé GM; Elias SC; Silk SE; Quinkert D; Jin J; Marshall JM; Payne RO; Minassian AM; Russell B; Rénia L; Nosten FH; Moon RW; Higgins MK; Draper SJ
    Nat Microbiol; 2019 Sep; 4(9):1497-1507. PubMed ID: 31133755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium vivax GPI-anchored micronemal antigen (PvGAMA) binds human erythrocytes independent of Duffy antigen status.
    Cheng Y; Lu F; Wang B; Li J; Han JH; Ito D; Kong DH; Jiang L; Wu J; Ha KS; Takashima E; Sattabongkot J; Cao J; Nyunt MH; Kyaw MP; Desai SA; Miller LH; Tsuboi T; Han ET
    Sci Rep; 2016 Oct; 6():35581. PubMed ID: 27759110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human monoclonal antibodies inhibit invasion of transgenic Plasmodium knowlesi expressing Plasmodium vivax Duffy binding protein.
    Watson QD; Carias LL; Malachin A; Redinger KR; Bosch J; Bardelli M; Baldor L; Feufack-Donfack LB; Popovici J; Moon RW; Draper SJ; Zimmerman PA; King CL
    Malar J; 2023 Dec; 22(1):369. PubMed ID: 38049801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of recombinant PvDBPII, receptor binding domain of Plasmodium vivax Duffy binding protein, and evaluation of immunogenicity to identify an adjuvant formulation for vaccine development.
    Bhardwaj R; Shakri AR; Hans D; Gupta P; Fernandez-Becerra C; Del Portillo HA; Pandey G; Chitnis CE
    Protein Expr Purif; 2017 Aug; 136():52-57. PubMed ID: 26578115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent Origin and Global Distribution of Distinct Plasmodium vivax Duffy Binding Protein Gene Duplications.
    Hostetler JB; Lo E; Kanjee U; Amaratunga C; Suon S; Sreng S; Mao S; Yewhalaw D; Mascarenhas A; Kwiatkowski DP; Ferreira MU; Rathod PK; Yan G; Fairhurst RM; Duraisingh MT; Rayner JC
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005091. PubMed ID: 27798646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies raised against receptor-binding domain of Plasmodium knowlesi Duffy binding protein inhibit erythrocyte invasion.
    Singh AP; Puri SK; Chitnis CE
    Mol Biochem Parasitol; 2002 Apr; 121(1):21-31. PubMed ID: 11985860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulphated tyrosines mediate association of chemokines and Plasmodium vivax Duffy binding protein with the Duffy antigen/receptor for chemokines (DARC).
    Choe H; Moore MJ; Owens CM; Wright PL; Vasilieva N; Li W; Singh AP; Shakri R; Chitnis CE; Farzan M
    Mol Microbiol; 2005 Mar; 55(5):1413-22. PubMed ID: 15720550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium simium, a Plasmodium vivax-related malaria parasite: genetic variability of Duffy binding protein II and the Duffy antigen/receptor for chemokines.
    Camargos Costa D; Pereira de Assis GM; de Souza Silva FA; Araújo FC; de Souza Junior JC; Braga Hirano ZM; Satiko Kano F; Nóbrega de Sousa T; Carvalho LH; Ferreira Alves de Brito C
    PLoS One; 2015; 10(6):e0131339. PubMed ID: 26107662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of inhibitory anti-Duffy binding protein II immunity: approach to Plasmodium vivax vaccine development in Thailand.
    Chootong P; Panichakul T; Permmongkol C; Barnes SJ; Udomsangpetch R; Adams JH
    PLoS One; 2012; 7(4):e35769. PubMed ID: 22558221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The enigmatic mechanisms by which Plasmodium vivax infects Duffy-negative individuals.
    Popovici J; Roesch C; Rougeron V
    PLoS Pathog; 2020 Feb; 16(2):e1008258. PubMed ID: 32078643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection.
    King CL; Michon P; Shakri AR; Marcotty A; Stanisic D; Zimmerman PA; Cole-Tobian JL; Mueller I; Chitnis CE
    Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8363-8. PubMed ID: 18523022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.